secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0001193125-25-317728
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Iterum Therapeutics receives Nasdaq delisting notice for MVLS below $35M
------------------------------------------------------------------------

- Nasdaq notified Iterum on Dec 11, 2025 that MVLS <$35M for 30 consecutive business days; given 180 days until June 9, 2026 to regain compliance.
- Company also remains out of compliance with $1.00 minimum bid price rule since August 2025, with compliance period ending Feb 23, 2026.
- Failure to cure either deficiency could lead to delisting; company may appeal but no assurance of success.
- Notice has no immediate effect on listing; common stock continues trading on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000119312525317728/0001193125-25-317728-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000119312525317728/itrm-20251211.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-317728

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer